TOP PAGE
ENGLISH
JAPANESE
|
CONNECT WITH US:
Home
About
Services
Contact
Log in
*
Home
Press release
May 18, 2020 13:24 JST
Source:
Hitachi, Ltd.
Hitachi to Provide $1 Million in Loans through Kiva to Businesses in Need around the Globe, Affected by the Spread of the COVID-19
TOKYO, May 18, 2020 - (JCN Newswire) - Hitachi, Ltd. (TSE: 6501) today announced that it will make a contribution of USD 1 million to Kiva's COVID-19 Response to support business owners impacted by COVID-19 through loans by Kiva, a U.S. nonprofit organization that supports lending to small businesses, entrepreneurs, farmers and families around the world through crowdfunding. Hitachi is a first major contributor to Kiva's Global COVID-19 fund, a new program that will allow Kiva to fund the communities that have been hit hardest by this crisis. As repayments from these loans return to Hitachi's account, they will fund new loans over a 4-year period, after which the balance will be a donation to Kiva.
Kiva is a global nonprofit organization whose mission is to expand financial access to underserved communities and the 1.7 billion people in the world who do not have access to financial services. Kiva facilitates loans to borrowers through their online crowdfunding platform, and to date 1.9 million people have funded over USD 1.44 billion in loans to 3.6 million borrowers in 77 countries. Hitachi has made a new contribution of USD 1 million to Hitachi's Kiva fund to support small business operators affected by the spread of the COVID-19, in addition to the first contribution of USD 100,000 in 2017.
Specifically, Hitachi Group employees will have an opportunity to choose business owners affected by COVID-19, and make a loan of USD 25 from the Hitachi fund. Hitachi also hopes to engage their community in Kiva's COVID-19 response through Hitachi's social media accounts. Individuals who make a loan on Kiva first, will receive an additional USD 25 credit on behalf of Hitachi, to lend to another borrower. Any remaining funds will be used to match loans made on the Kiva platform. By engaging employees and the community, Hitachi will provide financial support of USD 1 million in total to the small business operators all over the world.
Comment from Hidenobu Nakahata, Senior Vice President and Executive Officer, CHRO, Hitachi, Ltd.
"All Hitachi employees are working on the COVID-19 spread prevention by collecting ideas in the Hitachi Group internal idea contest "Make a difference!" in addition to supplying masks and other goods and manufacturing and providing face shields free of charge. The loans through the Kiva platform are realized by "Make a difference!". Hitachi will contribute to realization of a sustainable society through Hitachi's employees' proactive commitment to financial support through Kiva for the business operators affected by the spread of COVID-19."
Comment from Neville Crawley, CEO at Kiva
"At Kiva, we are incredibly proud to launch a COVID-19 response fund with the support of Hitachi. It is through this response that we are able to accelerate the necessary loans required to support all people when they need it the most. Currently, we are seeing a financial support gap, the most vulnerable are being left behind and we need to provide our support to them. Our vision has always been financial inclusivity and now it is more important than ever. We thank Hitachi and their amazing employees for their support."
Join Hitachi's social media community and help small business owners around the world affected by the pandemic through KIVA.
About Hitachi, Ltd.
Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan, is focusing on Social Innovation Business combining its operational technology, information technology and products. The company's consolidated revenues for fiscal 2018 (ended March 31, 2019) totaled 9,480.6 billion yen ($85.4 billion), and the company has approximately 296,000 employees worldwide. Hitachi delivers digital solutions utilizing Lumada in five sectors including Mobility, Smart Life, Industry, Energy and IT, to increase our customer's social, environmental and economic value. For more information on Hitachi, please visit the company's website at
https://www.hitachi.com
.
Source: Hitachi, Ltd.
Sectors: Daily News
Copyright ©2025 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Related Press Release
Hitachi Employee Receives the "Chop Wood Carry Water Award" from the Global OSS Organization CNCF for Leading the Establishment of Official Community in Japan
November 14 2025 20:06 JST
Hitachi and Tobu Railway launched a co-creation initiative to deliver HMAX on Japanese railways
November 11 2025 16:35 JST
Hitachi High-Tech Announces the SU9600: Next-Generation Ultrahigh-Resolution Scanning Electron Microscope with High Throughput
October 31 2025 23:45 JST
Hitachi Energy and Blackstone Energy Transition Partners enter strategic partnership to create leading energy service provider in North America
October 30 2025 20:40 JST
Hitachi Rail becomes world's first transportation firm to adopt new NVIDIA IGX Thor solution for real-time AI
October 30 2025 10:00 JST
Hitachi announces initiatives aligned with Japan - U.S. strategic investments
October 28 2025 21:34 JST
Hitachi and OpenAI form strategic partnership centered on global AI data center expansion
October 21 2025 19:06 JST
Hitachi Advances Strategic Alliance with Google Cloud to Empower Frontline Workers with Field-Specific AI Agents
October 10 2025 23:58 JST
The Second Proton Therapy System Begins Treatment at University of Tsukuba Hospital
October 01 2025 19:37 JST
Hitachi Energy invests an additional $270 million CAD ($195 million USD) to expand large power transformer manufacturing capacity in Varennes, Quebec
October 01 2025 18:33 JST
More Press release >>
Latest Press Release
The 26th Hong Kong Forum marks successful completion
Dec 03, 2025 22:44 JST
Anime Tokyo Station: Celebrating the 25th Anniversaries of Two Popular Anime with an Anniversary Joint Exhibition Starting November 15
Dec 03, 2025 11:30 JST
Eisai Presents New Data on Anti-Tau Antibody Etalanetug (E2814) at CTAD 2025
Dec 03, 2025 00:01 JST
NEC Launches AI Agent Service in Japan to Automate Procurement Negotiations Using AI
Dec 02, 2025 23:43 JST
Fujitsu develops new technology to support human-robot collaboration
Dec 02, 2025 23:26 JST
Fujitsu establishes international consortium to tackle disinformation/misinformation and new AI risks
Dec 02, 2025 22:55 JST
Fujitsu achieves high-precision, long-duration molecular dynamics simulation for all-solid-state battery interphases with over 100,000 atoms
Dec 01, 2025 23:04 JST
Fujitsu develops multi-AI agent collaboration technology to optimize supply chains, launches joint trials
Dec 01, 2025 22:43 JST
Fujitsu launches 'Fujitsu Accelerator Program for SPORTS' to create new value through Sports x Technology
Dec 01, 2025 22:14 JST
Eisai Submits New Drug Application for Subcutaneous Formulation of "LEQEMBI(R)" for the Treatment of Early Alzheimer's Disease in Japan
Nov 28, 2025 23:00 JST
JFCR, NEC, and Taiho to Develop Cancer Vaccines Utilizing Whole-Genome Information
Nov 28, 2025 19:41 JST
MHI Publishes "MHI REPORT 2025" and "SUSTAINABILITY DATABOOK 2025"
Nov 28, 2025 19:05 JST
Sharp Wins IAM's "Asia IP Elite 2025", Awarded to Companies with Outstanding Intellectual Property Strategy for The Second Consecutive Year
Nov 28, 2025 18:36 JST
Fujitsu builds platform for NSK to create environmental value throughout the product lifecycle of bearing products
Nov 28, 2025 18:01 JST
Fujitsu launches Japan Edition of SAP Fioneer Cloud for Insurance, a next-generation platform supporting core business operations in the Japanese insurance industry
Nov 28, 2025 17:28 JST
NEC Launches Sales Support Solution Utilizing Agentic AI
Nov 27, 2025 22:31 JST
Fujitsu and Yamaguchi University develop low-power edge computing technology for near real-time image processing on small satellites
Nov 27, 2025 22:00 JST
World's first ever spiral escalator renewal project conducted at a commercial facility in Mexico
Nov 27, 2025 11:00 JST
Eisai Completes Rolling Submission to US FDA for LEQEMBI(R) IQLIK(TM) (lecanemabirmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease Under Fast Track Status
Nov 26, 2025 19:42 JST
Fujitsu accelerates blue carbon certification with ocean digital twin technology
Nov 26, 2025 19:05 JST
More Latest Release >>